Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new pharmacology--drugging stressed folding pathways.

R Luke Wiseman1, William E Balch

  • 1Department of Chemistry and The Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Rd, MB-6, La Jolla, CA 92037, USA.

Trends in Molecular Medicine
|July 12, 2005
PubMed
Summary

Small molecules targeting the eIF2alpha factor may rebalance protein synthesis and endoplasmic reticulum-assisted folding (ERAF). This approach could correct diseases caused by protein misfolding and restore cellular folding capacity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DM: a simple solution to suppress air-water interface interactions in cryo-EM.

bioRxiv : the preprint server for biology·2026
Same author

Pharmacological Inhibition of SLC33A1 Promotes Endoplasmic Reticulum Hyperoxidation and Induces Adaptive IRE1/XBP1s Signaling.

bioRxiv : the preprint server for biology·2026
Same author

Phenylhydrazone-based endoplasmic reticulum proteostasis regulator compounds with enhanced biological activity.

eLife·2026
Same author

Drug repurposing screen identifies an HRI activating compound that promotes adaptive mitochondrial remodeling in MFN2-deficient cells.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Improving Proteostasis of Trafficking-Deficient GABA<sub>A</sub> Receptor Variants by Activating IRE1.

ACS chemical neuroscience·2025
Same author

Pharmacological targeting of RIG-I can selectively activate the integrated stress response.

Science advances·2025

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Protein folding in the endoplasmic reticulum (ER) is crucial for cellular function.
  • Imbalances in chaperone-mediated folding are linked to diseases like diabetes.
  • The unfolded-protein response (UPR) is activated by misfolded proteins.

Purpose of the Study:

  • To explore small-molecule inhibitors for rebalancing protein synthesis and ER-assisted folding (ERAF).
  • To investigate the role of the ribosomal initiating factor eIF2alpha in this process.
  • To propose a novel therapeutic strategy for protein misfolding diseases.

Main Methods:

  • Investigated the coupling of protein synthesis and ERAF pathways.
  • Examined the role of the unfolded-protein response (UPR).

Related Experiment Videos

  • Focused on small-molecule modulation of the eIF2alpha factor.

    • Main Results:

    • Small-molecule inhibitors show potential for rebalancing protein synthesis and ERAF.
    • Targeting eIF2alpha may offer a way to correct folding imbalances.
    • Reprogramming stress pathways is a viable therapeutic avenue.

    Conclusions:

    • Modulating eIF2alpha with small molecules presents a promising strategy for treating protein misfolding diseases.
    • Balancing ER protein load with cellular folding capacity can be achieved through drug intervention.
    • This approach offers a new way to correct disease-associated folding defects.